<p>在過去一週，Numans Health Food Holdings (HKG:2530) 的股價下跌了 11%，因此很容易忽視它。考慮到股價通常是由公司的基本面驅動的，而在這種情況下基本面看起來相當疲弱，我們決定研究該公司的關鍵財務指標。具體來説，我們決定在本文中研究 Numans Health Food Holdings 的股本回報率（ROE）。</p>
<p>股本回報率（ROE）是評估公司如何有效地利用股東投資產生回報的有用工具。簡而言之，ROE 顯示每一美元的股東投資所產生的利潤。</p>
<p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。查看完整列表，免費獲取。</p>
<h2>ROE 是如何計算的？</h2>
<p><strong>股本回報率可以通過以下公式計算：</strong></p>
<p>股本回報率 = 淨利潤（來自持續經營）÷ 股東權益</p>
<p>因此，根據上述公式，Numans Health Food Holdings 的 ROE 為：</p>
<p>6.4% = CN¥3200 萬 ÷ CN¥4.96 億（基於截至 2025 年 6 月的過去十二個月）。</p>
<p>“回報” 是指過去十二個月的税後收益。可以這樣理解：對於每 HK$1 的股東資本，公司賺取了 HK$0.06 的利潤。</p>
<p>查看我們對 Numans Health Food Holdings 的最新分析</p>
<h2>為什麼 ROE 對盈利增長很重要？</h2>
<p>我們已經確定 ROE 是評估公司未來盈利的有效利潤生成指標。根據公司再投資或 “保留” 這些利潤的程度，以及其有效性，我們能夠評估公司的盈利增長潛力。一般來説，其他條件相同，具有高股本回報率和利潤保留的公司，其增長率高於沒有這些特徵的公司。</p>
<h2>Numans Health Food Holdings 的盈利增長與 6.4% ROE 的並列比較</h2>
<p>乍一看，Numans Health Food Holdings 的 ROE 並不值得一提。進一步研究顯示，該公司的 ROE 與行業平均水平 11% 相比也不太理想。在這種情況下，Numans Health Food Holdings 在過去五年中淨收入下降 19% 並不令人驚訝。我們認為這裏可能還有其他因素在起作用。例如，可能是公司資本配置不當，或者公司有非常高的派息比率。</p>
<p>然而，當我們將 Numans Health Food Holdings 的增長與行業進行比較時，我們發現儘管公司的盈利在縮減，但行業在同一時期的盈利增長達到了 14%。這相當令人擔憂。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308"/></p>
<p>SEHK:2530 過去的盈利增長 2026 年 1 月 12 日</p>
<p>盈利增長是評估股票價值時需要考慮的重要指標。投資者接下來需要確定預期的盈利增長或缺乏盈利增長是否已經反映在股價中。通過這樣做，他們將能夠判斷股票是朝着清澈的水域前進，還是面臨泥濘的水域。如果你想了解 Numans Health Food Holdings 的估值，請查看其市盈率與行業的比較。</p>
<h2>Numans Health Food Holdings 是否有效地再投資其利潤？</h2>
<p>考慮到公司將大部分利潤用於支付股息，Numans Health Food Holdings 盈利下降並不令人驚訝，依據其三年中位派息比率為 76%（或保留比率為 24%）。公司僅剩下少量資本用於再投資——這是一種對公司長期不利的惡性循環。要了解我們為 Numans Health Food Holdings 確定的 4 個風險，請訪問我們的風險儀表板，免費獲取。</p>
<p>此外，Numans Health Food Holdings 最近才開始支付股息，因此管理層可能認為股東更喜歡股息，儘管盈利在縮減。</p>
<h2>結論</h2>
<p>總體而言，在對 Numans Health Food Holdings 做出任何決策之前，我們會非常謹慎。由於公司沒有將太多資金再投資於業務，加上 ROE 較低，看到其盈利缺乏或沒有增長並不令人驚訝。到目前為止，我們僅對公司的盈利增長進行了快速討論。要進一步瞭解 Numans Health Food Holdings 過去的利潤增長，請查看過去盈利、收入和現金流的可視化。</p>

紐曼思

<p>紐曼思健康食品控股（HKG:2530）股價下跌了 11%，原因歸咎於基本面疲弱。該公司的股本回報率（ROE）為 6.4%，顯著低於行業平均水平的 11%。在過去五年中，淨收入下降了 19%，而行業則增長了 14%。76% 的高分紅支付比率限制了對業務的再投資，導致盈利停滯。由於公司低 ROE 和缺乏增長潛力，投資者應保持謹慎</p>

<p>With its stock down 11% over the past week, it is easy to disregard Numans Health Food Holdings (HKG:2530). Given that stock prices are usually driven by a company’s fundamentals over the long term, which in this case look pretty weak, we decided to study the company's key financial indicators. Specifically, we decided to study Numans Health Food Holdings' ROE in this article.</p>
<div class="lb-trans"><p>在過去一週，Numans Health Food Holdings (HKG:2530) 的股價下跌了 11%，因此很容易忽視它。考慮到股價通常是由公司的基本面驅動的，而在這種情況下基本面看起來相當疲弱，我們決定研究該公司的關鍵財務指標。具體來説，我們決定在本文中研究 Numans Health Food Holdings 的股本回報率（ROE）。</p>
</div><p>ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.</p>
<div class="lb-trans"><p>股本回報率（ROE）是評估公司如何有效地利用股東投資產生回報的有用工具。簡而言之，ROE 顯示每一美元的股東投資所產生的利潤。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。查看完整列表，免費獲取。</p>
</div><h2>How Is ROE Calculated?</h2>
<div class="lb-trans"><h2>ROE 是如何計算的？</h2>
</div><p><strong>Return on equity can be calculated by using the formula:</strong></p>
<div class="lb-trans"><p><strong>股本回報率可以通過以下公式計算：</strong></p>
</div><p>Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity</p>
<div class="lb-trans"><p>股本回報率 = 淨利潤（來自持續經營）÷ 股東權益</p>
</div><p>So, based on the above formula, the ROE for Numans Health Food Holdings is:</p>
<div class="lb-trans"><p>因此，根據上述公式，Numans Health Food Holdings 的 ROE 為：</p>
</div><p>6.4% = CN¥32m ÷ CN¥496m (Based on the trailing twelve months to June 2025).</p>
<div class="lb-trans"><p>6.4% = CN¥3200 萬 ÷ CN¥4.96 億（基於截至 2025 年 6 月的過去十二個月）。</p>
</div><p>The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each HK$1 of shareholders' capital it has, the company made HK$0.06 in profit.</p>
<div class="lb-trans"><p>“回報” 是指過去十二個月的税後收益。可以這樣理解：對於每 HK$1 的股東資本，公司賺取了 HK$0.06 的利潤。</p>
</div><p>View our latest analysis for Numans Health Food Holdings</p>
<div class="lb-trans"><p>查看我們對 Numans Health Food Holdings 的最新分析</p>
</div><h2>Why Is ROE Important For Earnings Growth?</h2>
<div class="lb-trans"><h2>為什麼 ROE 對盈利增長很重要？</h2>
</div><p>We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Depending on how much of these profits the company reinvests or &#34;retains&#34;, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.</p>
<div class="lb-trans"><p>我們已經確定 ROE 是評估公司未來盈利的有效利潤生成指標。根據公司再投資或 “保留” 這些利潤的程度，以及其有效性，我們能夠評估公司的盈利增長潛力。一般來説，其他條件相同，具有高股本回報率和利潤保留的公司，其增長率高於沒有這些特徵的公司。</p>
</div><h2>A Side By Side comparison of Numans Health Food Holdings' Earnings Growth And 6.4% ROE</h2>
<div class="lb-trans"><h2>Numans Health Food Holdings 的盈利增長與 6.4% ROE 的並列比較</h2>
</div><p>On the face of it, Numans Health Food Holdings' ROE is not much to talk about. A quick further study shows that the company's ROE doesn't compare favorably to the industry average of 11% either. Given the circumstances, the significant decline in net income by 19% seen by Numans Health Food Holdings over the last five years is not surprising. We reckon that there could also be other factors at play here. For example, it is possible that the business has allocated capital poorly or that the company has a very high payout ratio.</p>
<div class="lb-trans"><p>乍一看，Numans Health Food Holdings 的 ROE 並不值得一提。進一步研究顯示，該公司的 ROE 與行業平均水平 11% 相比也不太理想。在這種情況下，Numans Health Food Holdings 在過去五年中淨收入下降 19% 並不令人驚訝。我們認為這裏可能還有其他因素在起作用。例如，可能是公司資本配置不當，或者公司有非常高的派息比率。</p>
</div><p>However, when we compared Numans Health Food Holdings' growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 14% in the same period. This is quite worrisome.</p>
<div class="lb-trans"><p>然而，當我們將 Numans Health Food Holdings 的增長與行業進行比較時，我們發現儘管公司的盈利在縮減，但行業在同一時期的盈利增長達到了 14%。這相當令人擔憂。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308" alt="" original-src="https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308"/></p>
<p>SEHK:2530 Past Earnings Growth January 12th 2026</p>
<div class="lb-trans"><p>SEHK:2530 過去的盈利增長 2026 年 1 月 12 日</p>
</div><p>Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Numans Health Food Holdings''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.</p>
<div class="lb-trans"><p>盈利增長是評估股票價值時需要考慮的重要指標。投資者接下來需要確定預期的盈利增長或缺乏盈利增長是否已經反映在股價中。通過這樣做，他們將能夠判斷股票是朝着清澈的水域前進，還是面臨泥濘的水域。如果你想了解 Numans Health Food Holdings 的估值，請查看其市盈率與行業的比較。</p>
</div><h2>Is Numans Health Food Holdings Efficiently Re-investing Its Profits?</h2>
<div class="lb-trans"><h2>Numans Health Food Holdings 是否有效地再投資其利潤？</h2>
</div><p>Numans Health Food Holdings' declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 76% (or a retention ratio of 24%). The business is only left with a small pool of capital to reinvest - A vicious cycle that doesn't benefit the company in the long-run. To know the 4 risks we have identified for Numans Health Food Holdings visit our risks dashboard for free.</p>
<div class="lb-trans"><p>考慮到公司將大部分利潤用於支付股息，Numans Health Food Holdings 盈利下降並不令人驚訝，依據其三年中位派息比率為 76%（或保留比率為 24%）。公司僅剩下少量資本用於再投資——這是一種對公司長期不利的惡性循環。要了解我們為 Numans Health Food Holdings 確定的 4 個風險，請訪問我們的風險儀表板，免費獲取。</p>
</div><p>In addition, Numans Health Food Holdings only recently started paying a dividend so the management probably decided the shareholders prefer dividends even though earnings have been shrinking.</p>
<div class="lb-trans"><p>此外，Numans Health Food Holdings 最近才開始支付股息，因此管理層可能認為股東更喜歡股息，儘管盈利在縮減。</p>
</div><h2>Conclusion</h2>
<div class="lb-trans"><h2>結論</h2>
</div><p>Overall, we would be extremely cautious before making any decision on Numans Health Food Holdings. Because the company is not reinvesting much into the business, and given the low ROE, it's not surprising to see the lack or absence of growth in its earnings. So far, we've only made a quick discussion around the company's earnings growth. To gain further insights into Numans Health Food Holdings' past profit growth, check out this visualization of past earnings, revenue and cash flows.</p>
<div class="lb-trans"><p>總體而言，在對 Numans Health Food Holdings 做出任何決策之前，我們會非常謹慎。由於公司沒有將太多資金再投資於業務，加上 ROE 較低，看到其盈利缺乏或沒有增長並不令人驚訝。到目前為止，我們僅對公司的盈利增長進行了快速討論。要進一步瞭解 Numans Health Food Holdings 過去的利潤增長，請查看過去盈利、收入和現金流的可視化。</p>
</div>

紐曼思健康食品控股有限公司（HKG:2530）的股票正在下跌：是否是由於基本面不佳所致？